Zantac / Ranitidine Cancer
vs. Sanofi / Pfizer / GSK
Heartburn drug Zantac recalled after FDA found it contained NDMA, a probable carcinogen linked to bladder, stomach, and colon cancers.
2020
pending
Accepting cases
Latest News & Updates
Zantac Suits Tossed by Delaware Judge for Flawed Cancer Link
A Delaware judge threw out lawsuits seeking to link the heartburn drug Zantac to cancer, freeing makers of the product from facing trials in the state over the cases. Superior Court Judge Francis “Pete” Jones concluded Monday lawyers for ex-Zantac …
Articles & Resources
Understanding Your Rights in the Zantac / Ranitidine Cancer Case
Learn what you need to know about eligibility, deadlines, and the claims process.
Settlement Distribution Timeline for Zantac / Ranitidine Cancer
What to expect after a settlement is approved and how compensation is distributed.
FAQs: Common Questions About Zantac / Ranitidine Cancer
Answers to frequently asked questions about eligibility, compensation, and the legal process.
Why You Should File Your Claim Before the Deadline
Understanding statute of limitations and why timing matters in class action lawsuits.
Frequently Asked Questions
Ready to Join This Case?
Connect with experienced class action attorneys who can evaluate your claim and guide you through the process. No upfront fees required.
Related Cases
Depo-Provera Brain Tumor (Meningioma)
Women who used Depo-Provera birth control injections developed intracranial meningioma brain tumors. French studies show 5.6x increased risk. Cases now being filed nationwide.
Paraquat Parkinson's Disease
Farmworkers and rural residents allege paraquat herbicide exposure caused Parkinson's disease. Thousands of cases pending in federal MDL.
Hair Relaxer Uterine Cancer
NIH study links chemical hair relaxers to uterine cancer. Class action filed against major manufacturers for failing to warn consumers of cancer risk.